The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lumexa Imaging Holdings Inc
NASDAQ:LMRI
|
US |
|
A
|
ALD SA
PAR:AYV
|
FR |
|
E
|
Enel SpA
DUS:ENL
|
IT |
|
S
|
Sompo Holdings Inc
OTC:NHOLF
|
JP |
|
I
|
Impala Platinum Holdings Ltd
XMUN:IPHB
|
ZA |
|
S
|
Sunrun Inc
SWB:3S9
|
US |
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
B
|
Bureau Veritas SA
DUS:4BV
|
FR |
|
B
|
BCWorldPharm Co Ltd
KOSDAQ:200780
|
KR |
|
X
|
XPO Inc
F:UX2A
|
US |
|
Darma Henwa Tbk PT
F:0DH
|
ID |
|
M
|
Muenchener Rueckversicherungs-Gesellschaft in Muenchen AG
XHAN:MUV2
|
DE |
|
Pierce Group AB (publ)
STO:PIERCE
|
SE |
|
Chipotle Mexican Grill Inc
NYSE:CMG
|
US |
|
R
|
RWE AG
SWB:RWEA
|
DE |
|
D
|
Daios Plastics SA
ATHEX:DAIOS
|
GR |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
|
F
|
freenet AG
F:FNA
|
DE |
|
F
|
Fomento Economico Mexicano SAB de CV
SWB:FOMA
|
MX |
|
L
|
Lepermislibre SA
F:I5T
|
FR |
|
C
|
Cahya Mata Sarawak Bhd
KLSE:CMSB
|
MY |
|
H
|
HSBC Holdings PLC
F:HBC2
|
UK |
|
K
|
K92 Mining Inc
OTC:KNTNF
|
CA |
Lumexa Imaging Holdings Inc (LMRI)’s 12-month stock price forecast through October 2027 has a consensus target of $17.34, implying 72% upside. The forecast is based on price targets from 10 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for LMRI is 17.34 USD with a low forecast of 13.13 USD and a high forecast of 24.15 USD.
Over the last 1 year, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 6%.
Over the last 1 year, the compound annual growth rate for Gross Profit has been 64%. The projected CAGR for the next 3 years is 12%.
The compound annual growth rate for Operating Income over the next 3 years is 98%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more